Medical News

---

• Obese children need propofol dose adjustment
• High-throughput sequencing best predicts early leukemia relapse
• Research supports immune dysfunction in bipolar disorder
• Heavy smoking linked to high cholesterol in schizophrenia patients
• End-of-life care lacking in nursing homes
• Sting in the tail for bee pollen users
• Poles lead the way for heart failure patients
• Clopidogrel reaches milestone
• PPAR-γ role in ‘unique’ adipose tissue Treg-cell function
• Statin guidelines ‘should be reconsidered’
• More evidence for statin acute stroke benefits
• Bone screening recommended for COPD veterans
• More evidence for statin acute stroke benefits
• Clopidogrel reaches milestone

Obese children need propofol dose adjustment Posted: 22 May 2012 05:00 PM PDT Obese children lose consciousness at a significantly lower propofol dose than children with a healthy body mass index, shows research.

High-throughput sequencing best predicts early leukemia relapse Posted: 22 May 2012 05:00 PM PDT High-throughput sequencing of T-cell receptor genes detects early signs of potential relapse in nearly twice as many leukemia patients as does-flow cytometry, the current gold standard for detecting minimal residual disease, US researchers report.

Research supports immune dysfunction in bipolar disorder Posted: 22 May 2012 05:00 PM PDT Patients with bipolar disorder display altered plasma chemokine profiles compared with mentally healthy individuals, indicating that the mood disorder is associated with immune dysfunction.

Heavy smoking linked to high cholesterol in schizophrenia patients Posted: 22 May 2012 05:00 PM PDT Patients with schizophrenia who are heavy smokers have higher cholesterol levels, and are more likely to use alcohol, cocaine, and other substances than those who are not heavy smokers.

End-of-life care lacking in nursing homes Posted: 22 May 2012 05:00 PM PDT Staff in care homes need extra education and support to improve their delivery of end-of-life care to people with dementia, researchers believe.

Sting in the tail for bee pollen users Posted: 22 May 2012 05:00 PM PDT Bee pollen supplements, taken as a natural health product, can cause severe anaphylactic reactions, particularly in people allergic to airborne pollens, Canadian researchers report.

Poles lead the way for heart failure patients Posted: 21 May 2012 05:00 PM PDT Nordic walking could allow heart failure patients to exercise more effectively than walking without poles, researchers say.

Clopidogrel reaches milestone Posted: 21 May 2012 05:00 PM PDT The US Food and Drug Administration has approved generic versions of the oral thienopyridine antiplatelet agent clopidogrel.

PPAR-γ role in ‘unique’ adipose tissue Treg-cell function Posted: 21 May 2012 05:00 PM PDT The beneficial effects of T regulatory cells in visceral adipose tissue are mediated partly by peroxisome proliferator-activated receptor-γ, researchers report in Nature.

Statin guidelines ‘should be reconsidered’ Posted: 21 May 2012 05:00 PM PDT Statin therapy reduces the risk for major vascular events by around 20% in a wide range of individuals, including those with no previous history of vascular disease, show results of a meta-analysis published in The Lancet.

More evidence for statin acute stroke benefits Posted: 21 May 2012 05:00 PM PDT Patients who take statins before and during hospitalization for a stroke have an improved chance of being discharged home, rather than to a nursing facility, a large US study suggests.

Bone screening recommended for COPD veterans Posted: 21 May 2012 05:00 PM PDT Male veterans with chronic obstructive pulmonary disease should be screened for osteoporosis, say US researchers who found a high untreated prevalence of the disease in this population.

More evidence for statin acute stroke benefits Posted: 21 May 2012 05:00 PM PDT Patients who take statins before and during hospitalization for a stroke have an improved chance of being discharged home, rather than to a nursing facility, a large US study suggests.

Clopidogrel reaches milestone Posted: 21 May 2012 05:00 PM PDT The US Food and Drug Administration has approved generic versions of the oral thienopyridine antiplatelet agent clopidogrel.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610